Federal Cancer Education Grant Rule Finally Retired
Published Date: 7/7/2026
Proposed Rule
Summary
The government is getting rid of an old rule about grants for the National Cancer Institute’s Clinical Cancer Education Program because it’s outdated and not needed anymore. This change affects anyone involved in those grants, but it won’t cost or save money. If you want to share your thoughts, you have until September 8, 2026, to speak up!
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
Rescinding NCI education grant rule
HHS proposes to remove the regulation at 42 CFR part 52d, which governed the National Cancer Institute Clinical Cancer Education Program, because it is obsolete (the program and its statutory basis changed since 1980 and section 404 of the Public Health Service Act no longer exists). NIH and HHS say this rescission is deregulatory, will not produce measurable cost savings, and they do not expect adverse impacts on stakeholders.
Grants continue under general grant rules
If 42 CFR part 52d is removed, NIH and HHS say NCI Cancer Education grant programs would continue to be governed by existing regulations such as 42 CFR part 52 (Grants for Research Projects) and 2 CFR part 200 (Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards). This means organizations involved with those grants will still follow the general federal grant rules.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16414, Adoption and Foster Care Analysis and Reporting System
This document withdraws a proposed rule that was published in the Federal Register on January 11, 2008. The proposed rule would have amended the Adoption and Foster Care Analysis and Reporting System (AFCARS) regulations at 45 CFR 1355.40 and the appendices to Part 1355 to modify the requirements for States to collect and report data to ACF on children in out-of-home care and in subsidized adoption or guardianship arrangements with the State. This document also withdraws the provision of the 2008 proposed rule that implemented the AFCARS penalty requirements of the Adoption Promotion Act of 2003 (Pub. L. 108-145).
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14709, Patient Protection and Affordable Care Act, HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program; Correction
This correction fixes some typos and technical mistakes in the 2027 health insurance rules under the Affordable Care Act. It mainly affects people and organizations involved in health coverage plans by clarifying when the rules take effect and restoring some important regulation details. These fixes take effect on July 20, 2026, ensuring smoother and clearer health plan operations next year.
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2026-12069, Medicare Program; Strengthening Oversight of Accrediting Organizations (AOs) and Preventing AO Conflicts of Interest, and Related Provisions
This new rule makes sure the groups that check Medicare providers play fair and follow clear rules to avoid conflicts of interest. It updates how psychiatric hospitals are reviewed and tightens rules for providers who lost their Medicare status but want back in. These changes affect Medicare providers and accrediting groups, start June 16, 2027, and aim to keep care safe and trustworthy.
Previous / Next Documents
Previous: 2026-13687, Implementation of the National Environmental Policy Act
The Nuclear Regulatory Commission is updating how it follows the National Environmental Policy Act to make reviews faster, clearer, and less of a hassle. These changes affect anyone applying for nuclear licenses or permits, cutting down on paperwork and focusing only on important environmental impacts. You’ve got until August 21, 2026, to share your thoughts before the new rules take shape!
Next: 2026-13719, Endangered and Threatened Wildlife and Plants; Threatened Species Status With Section 4(d) Rule for the Kern Canyon Slender Salamander and Endangered Species Status for the Relictual Slender Salamander; Designation of Critical Habitat
The U.S. Fish and Wildlife Service is proposing to protect two special salamanders: the Kern Canyon slender salamander as threatened with extra protections, and the relictual slender salamander as endangered. They’re also setting aside important habitats to help these salamanders survive. People have until August 6, 2026, to share their thoughts, and these protections could affect local land use and conservation funding.